Is Brexit a positive for the UK’s pharma sector? Here are seven factors in favour of this

Despite concern expressed by the pharmaceutical industry that the UK would suffer as a result of Brexit, Catalyst Corporate Finance, the UK business of Alantra, argues that the UK’s decision to leave the European Union in fact